Company Analysis

Altimmune, Inc. (ALT)

Nasdaq: ALT · Pharmaceutical Preparations · Gaithersburg, MD · filing with the SEC since 2005
Grade3.9
◀ Past 3.1● Present 3.5▶ Future 4.8
1 est.

Who runs Altimmune, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Durso Jerome Benedict
President and CEO. First filing Feb 2025, latest Aug 13, 2026, 4 filings in all.
Officers reporting now
9
of 18 people with a filing in the last fifteen months
Directors reporting now
9
32 people on the record since 2007
Officerssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Weaver Gregory LChief Financial OfficerNov 2024Oct 5, 2026none
Arbet-Engels ChristopheChief Medical OfficerOct 2025Oct 5, 2026none
Menziuso Richard ThomasPrincipal Accounting OfficerOct 2026Oct 2, 2026none
Richardson Linda MChief Commercial OfficerSep 2025Sep 17, 2026none
Durso Jerome BenedictPresident and CEOFeb 2025Aug 13, 2026none
Roberts M ScotChief Scientific OfficerMay 2017Aug 3, 2026none
Gill JohnPresident and CEOAug 2007May 1, 2026none
Garg Vipin KPresident and CEONov 2018Feb 2, 2026none
Jordt Raymond MChief Business OfficerJan 2023Feb 2, 2026none
Directorssales are open-market, Nov 4, 2025 to Nov 4, 2026
NameRoleFirst filingLatest filingSales, 12 months
Greenleaf PeterdirectorNov 2026Nov 4, 2026none
Howarth Alex G.directorNov 2026Nov 4, 2026none
Hodges PhilipdirectorMay 2017May 1, 2026none
Jorkasky DianedirectorMay 2020May 1, 2026none
Lawver Teri LdirectorFeb 2025May 1, 2026none
Pisano WaynedirectorSep 2018May 1, 2026none
Sayare MitcheldirectorApr 2010May 1, 2026none
Schafer KlausdirectorMay 2017May 1, 2026none
Sohn Catherine A.directorMar 2023May 1, 2026none
Earlier names on the record33, newest filing first
Harris Matthew Scott · officer · last filing Aug 2025Drutz David · director · last filing Aug 2024Shutterly Andrew · officer · last filing Aug 2024Eisenstadt Richard I · officer · last filing Feb 2024Brown William Michael · officer · last filing Aug 2021Koh Bong Y · 10% owner · last filing Mar 2021Shah Nimish P · 10% owner · last filing Mar 2021Venrock Healthcare Capital Partners II, L.P. · 10% owner · last filing Mar 2021Venrock Healthcare Capital Partners III, L.P. · 10% owner · last filing Mar 2021Vhcp Co-Investment Holdings II, LLC · 10% owner · last filing Mar 2021Vhcp Co-Investment Holdings III, LLC · 10% owner · last filing Mar 2021Vhcp Management II, LLC · 10% owner · last filing Mar 2021Vhcp Management III, LLC · 10% owner · last filing Mar 2021Velocity Pharmaceutical Holdings LLC · 10% owner · last filing May 2020Collier David J · 10% owner · last filing Feb 2020Velocity Pharma Management, LLC · 10% owner · last filing Feb 2020Watson James F · 10% owner · last filing Feb 2020Tasker Sybil · officer · last filing Jun 2019Novartis AG · 10% owner · last filing Oct 2018Novartis Bioventures Ltd · 10% owner · last filing Oct 2018Enright William · officer · last filing May 2018Truffle Capital S.A.S. · 10% owner · last filing Feb 2018Schaffer Derace L · officer · last filing Jan 2018Redmont Vaxn Capital Holdings, LLC · director · last filing Oct 2017Czerepak Elizabeth · officer · last filing Sep 2017Paradigm Venture Partners, L.P. · 10% owner · last filing May 2017Redmont Venture Partners, Inc. · 10% owner · last filing May 2017Runge Jeffrey W. · director · last filing Jan 2017St Peter Steven · director · last filing Jan 2017Macneill Philip · officer · last filing Dec 2016Frohlich Phil · 10% owner · last filing Dec 2016Prescott Group Capital Management, L.L.C. · 10% owner · last filing Dec 2016Richman Eric I · officer · last filing Nov 2016

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton ALT · research, not advice